Results from the IMpassion130 trial for triple-negative breast cancer Published 2018-10-29 Download video MP4 360p Download video MP4 720p Recommendations 06:13 The past, present and future of treating ovarian cancer 12:31 Early Breast Cancer: When to Consider Skipping Chemotherapy 41:53 Stem cell transplant: Patients reflect on their transplant journey 08:29 Gut bacteria and weight loss: Mayo Clinic Radio 17:13 Psychiatric Interviews for Teaching: Somatisation 06:21 What exciting updates on maintenance therapy in AML were presented at ASH 2023? 35:19 DocTalk Podcast: Understanding Lung Nodules 07:17 Dr. Valter Longo - Fasting Cycles Retard Growth of Tumors 10:08 Community-based breast cancer control programme in the Philippines 32:46 Nathan Adrian Explains Why the 100 Free World Record Will KEEP Getting Broken 22:20 Central Sensitization Syndrome (CSS) - Dr. Christopher Sletten 12:01 Alcohol Withdrawal 23:30 Addiction Neuroscience 101 09:15 Caffeine, Health, and the Human Body 04:49 The role of task shifting in psycho-oncology 1:30:26 The Science of Pain Management 08:47 WHO global policies to accelerate cancer control in the ASEAN region 05:38 Supporting breast cancer patients in Vietnam 05:59 Global Focus on Cancer 04:59 The ABC Global Alliance’s work in improving the QoL for cancer patients Similar videos 04:33 I-O in TNBC: IMpassion130 Trial Design and Results 07:19 IMpassion130 Trial: OS Updates in Metastatic TNBC 04:56 Results from the IMpassion 130 trial treating metastatic breast cancer 05:59 IMpassion130: Atezolizumab and nab-paclitaxel in triple-negative breast cancer 07:08 IMpassion130: results of atezolizumab plus nab-paclitaxel for frontline TNBC 04:47 TNBC: Updated Efficacy Results From IMpassion130 06:56 IMpassion130 Trial Data on PD-L1+ Tumors in TNBC 08:42 Chemoimmunotherapy in TNBC: The IMpassion130 Trial 01:09 Joyce O’Shaughnessy, MD, shares results of the Impassion130 trial presented at ESMO 2019 05:45 Case 3: Atezolizumab/Nab-Paclitaxel for Triple Negative Breast Cancer 01:46 Dr. Schmid Discusses the Findings of IMpassion130 in TNBC 02:30 IMpassion130: immunotherapy for TNBC 03:50 Breast cancer at ESMO 2020: IMpassion131, SOLAR-1, PALLAS and more 01:43 Dr. Rugo on the Results of the KEYNOTE-522 Trial in TNBC 10:06 Triple Negative Breast Cancer: What you need to know 01:00 IMpassion130: Implications 02:33 Applying IMpassion130 Data to TNBC Management 00:51 Debra Patt, MD, MPH, MBA, regarding the implications of the ImPassion130 trial in TNBC More results